Annals On Call Podcast
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
Latest episodes
Jun 23, 2020 • 25min
Clinical Reasoning and COVID-19 Part 2
In this episode of Annals On Call, Dr. Centor discusses diagnosis of COVID-19 with Drs. Ann Marie Kumfer and Sharmin Shekarchian.
Jun 4, 2020 • 21min
COVID-19 Disparities
In this episode of Annals On Call, Dr. Centor discusses health disparities and COVID-19 with Dr. Utibe Essien, the Director of the Center for Health Equity Research and Promotion at University of Pittsburgh.
May 12, 2020 • 27min
Clinical Reasoning and Testing for COVID-19
Dr. Centor discusses testing for COVID-19 with Drs. Rabih Geha and Reza Manesh.
May 4, 2020 • 31min
Striving to Decrease Hospital Infection
Dr. Centor discusses the prevention of catheter-associated urinary tract infection in hospitalized patients with Dr. Jennifer Meddings from the University of Michigan.
Apr 30, 2020 • 28min
Surge Modeling for COVID-19
Dr. Centor discusses COVID-19 pandemic surge models with Dr. John Wong from Tufts University.
Apr 20, 2020 • 22min
Impact of Estrogens After Hysterectomy
Dr. Centor discusses use of estrogen therapy in women who have had hysterectomy with bilateral salpingo-oophorectomy with Dr. JoAnn E. Manson.
Apr 9, 2020 • 25min
COVID-19: Is Chloroquine the Answer?
Dr. Centor discusses the evidence that generated interest in the potential role of hydroxychloroquine in the treatment of COVID-19.
Apr 6, 2020 • 22min
HPV Vaccination 2020
Dr. Centor discusses the appropriate use and cost-effectiveness of human papillomavirus vaccination with Dr. Sandra Adamson Fryhofer.
Mar 30, 2020 • 20min
Protecting Health Care Workers From COVID-19
Dr. Centor discusses strategies to protect health care workers from COVID-19 with Dr. Jeanne Marrazzo.
Mar 16, 2020 • 22min
SGLT2 Inhibitor-Associated Ketoacidosis--A History Lesson
Dr. Centor discusses ketoacidosis associated with SGLT2 inhibitors with Dr. Bruce Leslie. They discuss the history of the progenitor of SGLT2 inhibitors and how recognition of this history could have provided earlier alerts to this adverse effect of SGLT2 inhibitors.
